Stroger Hospital of Cook County, MBCCOP
库克县斯特罗格医院 MBCCOP
基本信息
- 批准号:8329141
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:African AmericanBrainBreastCancer ControlCancer PatientCaringChicagoClinical ResearchClinical TrialsCommunitiesControlled StudyCountyEastern Cooperative Oncology GroupEducation and OutreachFemaleGrowthHead and neck structureHealthHealth PersonnelHospitalsIllinoisIncidenceLungMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMethodsMinorityMinority-Based Community Clinical Oncology ProgramMorbidity - disease rateOncologistPatientsPreventionPrincipal InvestigatorProstateReproductive HistoryResearchSiteSystemUnderrepresented MinorityUnderserved Populationanticancer researchbasecancer carecontrol trialcookinggastrointestinalimprovedmortalitymultidisciplinarynew technologyoncologytertiary care
项目摘要
John H. Stroger Jr, Hospital of Cook County (SHCC) in Chicago, Illinois is the major tertiary care site for the Cook County Health and Hospital System (CCHHS). The majority of cancer cases are from minority-underserved populations, and are predominantly African American. SHCC plans to develop, strengthen and improve coordinated care and clinical research through the growth and expansion of the Minority-Based Community Clinical Oncology Program (MBCCOP). Dr. Thomas E. Lad will continue as Principal Investigator (PI). The SHCC MBCCOP will maintain and nurture relationships with current cancer research bases to facilitate broad and improved participation in treatment and prevention/control trials for breast, lung, prostate, gastrointestinal, brain, hematologic, head and neck, and gynecologic cancers; increase scientific activity at the research base level by initiating and chairing an ECOG group-wide cancer control study concerning reproductive issues of female cancer patients; increase support for oncologists and other cancer related healthcare providers; encourage multidisciplinary cancer care and integrated research; facilitate transfer of state-of-the-are quality oncology care and new technology to minority-underserved populations in their own communities through participation in NCl-approved clinical trials; focus on prevention and control as methods for reducing cancer incidence, morbidity and mortality and extend and promote research involvement and opportunities with emphasis on the particular needs of the community served, promoting outreach and education.
位于伊利诺伊州芝加哥的 John H. Stroger Jr 库克县医院 (SHCC) 是库克县健康和医院系统 (CCHHS) 的主要三级护理机构。大多数癌症病例来自服务不足的少数群体,并且主要是非裔美国人。 SHCC 计划通过发展和扩大少数民族社区临床肿瘤学计划 (MBCCOP) 来开发、加强和改善协调护理和临床研究。 Thomas E. Lad 博士将继续担任首席研究员 (PI)。 SHCC MBCCOP 将维持和培育与现有癌症研究基地的关系,以促进广泛和更好地参与乳腺癌、肺癌、前列腺癌、胃肠道癌、脑癌、血液癌、头颈癌和妇科癌症的治疗和预防/控制试验;通过发起和主持一项涉及女性癌症患者生殖问题的 ECOG 全集团癌症控制研究,增加研究基础层面的科学活动;增加对肿瘤学家和其他癌症相关医疗保健提供者的支持;鼓励多学科癌症护理和综合研究;通过参与 NCl 批准的临床试验,促进向其所在社区中服务不足的少数群体转移最先进的优质肿瘤护理和新技术;重点关注预防和控制作为降低癌症发病率、发病率和死亡率的方法,并扩大和促进研究参与和机会,重点关注所服务社区的特殊需求,促进外展和教育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas Lad其他文献
Thomas Lad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas Lad', 18)}}的其他基金
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
库克县斯特罗格医院 (SHCC) MU-NCORP 更新
- 批准号:
10453531 - 财政年份:2014
- 资助金额:
$ 5万 - 项目类别:
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
库克县斯特罗格医院 (SHCC) MU-NCORP 更新
- 批准号:
10672246 - 财政年份:2014
- 资助金额:
$ 5万 - 项目类别:
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
库克县斯特罗格医院 (SHCC) MU-NCORP 更新
- 批准号:
10226950 - 财政年份:2014
- 资助金额:
$ 5万 - 项目类别:
Stroger Hospital of Cook County, Department of Surgery,*
库克县斯特罗格医院外科,*
- 批准号:
7932699 - 财政年份:2002
- 资助金额:
$ 5万 - 项目类别:
相似国自然基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
- 批准号:81801389
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
- 批准号:81101046
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Roles of Glial Autophagy in Breast Cancer Brain Metastasis
胶质细胞自噬在乳腺癌脑转移中的作用
- 批准号:
10660141 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Targeting FASN to eliminate metastatic breast cancer in the brain
靶向 FASN 消除脑部转移性乳腺癌
- 批准号:
10721671 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Targeting brain and bone metastases in metastatic breast cancer for improved patient survival
针对转移性乳腺癌的脑和骨转移,提高患者生存率
- 批准号:
10564604 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells
通过聚焦超声引导控制 HER2 CAR T 细胞治疗乳腺癌脑转移
- 批准号:
10668038 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
乳腺癌脑转移的增强病毒免疫疗法
- 批准号:
10803696 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Targeting DNA repair mechanisms by nanoparticles of RNA and radiosensitizer for enhancing treatment of brain metastases of breast cancer
通过 RNA 纳米颗粒和放射增敏剂靶向 DNA 修复机制,增强乳腺癌脑转移的治疗
- 批准号:
488264 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Operating Grants
Novel drug delivery strategies for treatment of breast cancer brain metastases
治疗乳腺癌脑转移的新型药物递送策略
- 批准号:
10367645 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Role of breast cancer secreted miRNA in brain metastasis
乳腺癌分泌的miRNA在脑转移中的作用
- 批准号:
10342786 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Light Physical Activity for Brain Health in Older Adult Breast Cancer Survivors
轻度体力活动有利于老年乳腺癌幸存者的大脑健康
- 批准号:
10464004 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Assessment of cerebrospinal fluid ctDNA for the development of systemic therapy for brain metastases and leptomeningea disease of HER2-negative breast cancer
脑脊液 ctDNA 评估用于 HER2 阴性乳腺癌脑转移和软脑膜疾病全身治疗开发
- 批准号:
22K15565 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists